Inactive Instrument
Quotes GENFIT Euronext Paris
Stocks
FR0004163111
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
| 03/07 | Genfit soars on news of U.S. reimbursement for a product |  |
| 03/07 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
Basic data
Market Cap (EUR)
64,53,12,476
Market Cap (USD)
73,84,28,282
Net sales (EUR)
7,11,15,000
Net sales (USD)
8,13,76,588
Free-Float
86.88 %
Free-Float capitalization (EUR)
56,08,18,082
Free-Float capitalization (USD)
64,17,41,712
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 74Cr | |
| -1.29% | -3.11% | -0.35% | +3.09% | 4.92TCr | |
| +3.90% | -0.39% | +386.06% | +593.85% | 3.96TCr | |
| -1.70% | +4.46% | +5.93% | +60.25% | 3.47TCr | |
| -2.01% | -0.76% | +28.41% | -8.01% | 3.44TCr | |
| +0.06% | +0.34% | +2.38% | +34.38% | 2.71TCr | |
| +0.46% | -3.49% | - | - | 1.62TCr | |
| -0.04% | -0.09% | +72.42% | +115.55% | 1.54TCr | |
| +1.12% | +1.91% | +14.54% | +19.16% | 1.41TCr | |
| 0.00% | +1.36% | +18.43% | -30.79% | 1.3TCr | |
| Average | +0.06% | +0.03% | +65.98% | +98.43% | 2.44TCr | |
| Weighted average by Cap. | -0.05% | -0.18% | +79.44% | +123.32% |
Historical Quotes: GENFIT
| Date | Opening | High | Low | Close | Volume | Change |
|---|
- Stock Market
- Stocks
- GNFT Stock
- Stock
- Quotes GENFIT
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
